Skip to main content

Systemic Sclerosis clinical trials at UCSF

1 research study open to eligible people

Systemic sclerosis is a disease that causes hardening of the skin and other organs. UCSF is running a study to test the safety and effects of a drug called Vixarelimab in people with lung problems from this disease. This trial is currently looking for participants.

Showing trials for

Last updated: